The HIV-1 Nef protein has a dual role in T cell receptor signaling in infected CD4+ T lymphocytes

被引:26
|
作者
Neri, Francesca [1 ]
Giolo, Giorgia [1 ]
Potesta, Marina [1 ]
Petrini, Stefania [2 ]
Doria, Margherita [1 ]
机构
[1] Childrens Hosp Bambino Gesu, Lab Immunoinfectivol, I-00165 Rome, Italy
[2] Childrens Hosp Bambino Gesu, Confocal Laser Microscopy Core Facil, I-00165 Rome, Italy
关键词
HIV-1; Nef; CD4(+) T lymphocytes; TCR; T cell activation; NFAT; IL-2; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNOLOGICAL SYNAPSE; NUCLEAR-FACTOR; OPTIMAL INFECTIVITY; GENE-EXPRESSION; DOWN-REGULATION; P12(I) PROTEIN; IN-VITRO; KAPPA-B; ACTIVATION;
D O I
10.1016/j.virol.2010.11.018
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The phenotypic changes that are induced by immune activation in CD4(+) T lymphocytes provide an optimal environment for efficient HIV-1 replication in these cells. The pathogenic Nef protein of HIV-1 modulates the T cell receptor (TCR) signaling, but whether this has a positive or negative effect on cellular activation is a matter of debate. Here we have investigated the response to TCR stimulation of primary CD4(+) T lymphocytes infected with wt or Nef-deficient HIV-1. Results show that, in freshly isolated quiescent T cells, Nef superinduces NFAT and IL-2 production bypassing early TCR effector molecules. Conversely, the early phosphorylation of PLC-gamma 1, the induction of NFAT, and the expression of IL-2 are impaired by Nef in sub-optimally activated/resting T cells. Our data indicate that Nef has a dual role in the modulation of TCR signaling aimed at favoring HIV-1 replication and spread in both quiescent and metabolically active CD4(+) T lymphocytes. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:316 / 326
页数:11
相关论文
共 50 条
  • [1] THE ROLE OF VIF IN REPLICATION OF HIV-1 IN CD4+ T-LYMPHOCYTES
    GABUZDA, D
    LAWRENCE, K
    LANGHOFF, E
    TERWILLIGER, E
    DORFMAN, T
    SODROSKI, J
    HASELTINE, W
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1993, 6 (06) : 700 - 700
  • [2] In vivo analysis of Nef’s role in HIV-1 replication, systemic T cell activation and CD4+ T cell loss
    Richard L Watkins
    John L Foster
    J Victor Garcia
    Retrovirology, 12
  • [3] In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4+ T cell loss
    Watkins, Richard L.
    Foster, John L.
    Garcia, J. Victor
    RETROVIROLOGY, 2015, 12
  • [4] HIV-1 Nef: a multifaceted modulator of T cell receptor signaling
    Abraham, Libin
    Fackler, Oliver T.
    CELL COMMUNICATION AND SIGNALING, 2012, 10
  • [5] HIV-1 Nef: a multifaceted modulator of T cell receptor signaling
    Libin Abraham
    Oliver T Fackler
    Cell Communication and Signaling, 10
  • [6] HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes
    Vassena, Lia
    Giuliani, Erica
    Koppensteiner, Herwig
    Bolduan, Sebastian
    Schindler, Michael
    Doria, Margherita
    JOURNAL OF VIROLOGY, 2015, 89 (10) : 5687 - 5700
  • [7] ROLE OF HIV-1 NEF EXPRESSION IN ACTIVATION PATHWAYS IN CD4+ T-CELLS
    CARREER, R
    GROUX, H
    AMEISEN, JC
    CAPRON, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (05) : 523 - 527
  • [8] The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor Tim-3 in infected CD4+ T cells
    Jacob, Rajesh Abraham
    Edgar, Cassandra R.
    Prevost, Jeremie
    Trothen, Steven M.
    Lurie, Antony
    Mumby, Mitchell J.
    Galbraith, Alexa
    Kirchhoff, Frank
    Haeryfar, S. M. Mansour
    Finzi, Andres
    Dikeakos, Jimmy D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (03)
  • [9] Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1
    Keppler, Oliver T.
    Tibroni, Nadine
    Venzke, Stephanie
    Rauch, Susanne
    Fackler, Oliver T.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 79 (03) : 616 - 627
  • [10] The CD4+ T cell response to HIV-1
    Picker, LJ
    Maino, VC
    CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) : 381 - 386